Financial Gravity Asset Management’s Myriad Genetics MYGN Stock Holding History

Financial Gravity Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$0	Buy	+1	New	+$16	﹤0.01%	611
2019 Q4	$27K	Sell	36 -360	-91%	-$9.9K	0.02%	907
2019 Q3	$11K	Sell	396 -509	-56%	-$14.8K	0.01%	598
2019 Q2	$25K	Sell	905 -786	-46%	-$22.2K	0.02%	448
2019 Q1	$56K	Buy	+1,691	New	+$51.5K	0.05%	287
2018 Q3	$6K	Sell	137 -1,064	-89%	-$47.3K	0.01%	693
2018 Q2	$51K	Buy	1,201 +1,029	+598%	+$34.8K	0.05%	317
2018 Q1	$5K	Buy	+172	New	+$5.82K	0.01%	737

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Gravity Asset Management's MYGN Position: Q4 2020 in Review

Financial Gravity Asset Management opened a new position in Myriad Genetics (MYGN) in Q4 2020: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #611 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in MYGN as recently as Q4 2019.

Financial Gravity Asset Management first reported a position in MYGN in Q1 2018 and has held it in 8 quarters since. The position peaked at $56K in Q1 2019. 187 funds tracked by Wall St. Rank hold MYGN as of Q4 2020.

Financial Gravity Asset Management held 1 share of Myriad Genetics worth $0 as of Q4 2020.
Myriad Genetics was a new Financial Gravity Asset Management position in Q4 2020.
Myriad Genetics made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q4 2020, its #611 holding.
Financial Gravity Asset Management first reported a position in Myriad Genetics in Q1 2018 and has held it in 8 quarters since.
Financial Gravity Asset Management's Myriad Genetics position peaked at $56K in Q1 2019.
187 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2020.

Based on Financial Gravity Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.